神經修復和再生市場規模、佔有率和成長分析（按產品、按程序和按地區）：產業預測（2025-2032）

2023 年全球神經修復和再生市場規模價值 85 億美元，預計將從 2024 年的 95.5 億美元成長到 2032 年的 241.5 億美元，預測期內（2025-2032 年）的複合年成長率為 12.3%。

由於帕金森氏症、阿茲海默症和其他神經退化性疾病等神經系統疾病的盛行率不斷上升，神經修復和再生市場正在經歷顯著成長。產業領導者不斷創新開發先進治療方法，為這種需求激增提供補充。外科技術、生技藥品和醫療設備的技術進步顯著改善了治療效果，進一步支持了市場擴張。 COVID-10 大流行的持續影響擾亂了醫療服務並加劇了慢性病患者的症狀。儘管如此，隨著神經移植、幹細胞治療和神經保護藥物等治療方法的預期進展，前景仍然光明。正如阿茲海默症協會所強調的那樣，阿茲海默症在老齡化社會中的流行凸顯了市場對有效的神經修復解決方案日益成長的需求。

目錄

介紹

• 分析目的
• 市場覆蓋
• 定義

分析方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況與展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場動態
  • 驅動程式
  • 機會
  • 限制因素
  • 任務
• 波特的分析

關鍵市場觀察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場吸引力指數
• 生態系測繪
• IP分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 總體經濟指標
• 重大投資分析

神經修復和再生市場（按產品類型）

• 市場概覽
• 神經刺激和神經調節設備
• 生物材料

神經修復和再生市場（按應用）

• 市場概覽
• 周邊神經損傷
• 癲癇
• 帕金森氏症
• 阿茲海默症

神經修復和再生市場規模（按地區）

• 市場概覽
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
• 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
• 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2024年）

主要企業簡介

• Medtronic（US）
• Boston Scientific Corporation（US）
• Abbott Laboratories（US）
• Stryker Corporation（US）
• AxoGen, Inc.（US）
• Integra LifeSciences Holdings Corporation（US）
• Baxter International Inc.（US）
• Nevro Corp（US）
• LivaNova PLC（UK）
• Cyberonics Inc.（US）
• Orthofix Medical Inc.（US）
• Polyganics（Netherlands）
• Nuvectra Corporation（US）
• Polyganics BV（Netherlands）
• BioTime Inc.（US）
• Collagen Matrix, Inc.（US）
• Synovis Micro Companies Alliance, Inc.（US）
• StimGuard LLC（US）
• Nexeon MedSystems Inc.（US）
• Checkpoint Surgical, Inc.（US）

Global Nerve Repair and Regeneration Market size was valued at USD 8.5 billion in 2023 and is poised to grow from USD 9.55 billion in 2024 to USD 24.15 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The nerve repair and regeneration market is experiencing significant growth driven by the rising incidence of neurological disorders, such as Parkinson's, Alzheimer's, and other neurodegenerative diseases. This surge in demand is complemented by ongoing innovation from industry leaders who are developing advanced therapies. Technological advancements in surgical techniques, biologics, and medical equipment have greatly enhanced treatment efficacy, further propelling market expansion. The ongoing impacts of the COVID-19 pandemic have disrupted healthcare services, exacerbating symptoms in patients with chronic conditions. Nonetheless, the outlook remains positive, with anticipated advancements in therapies like nerve grafts, stem cell treatments, and neuroprotective drugs. As highlighted by the Alzheimer's Association, the prevalence of Alzheimer's disease in the aging population underscores the growing need for effective nerve repair solutions in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair and Regeneration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair and Regeneration Market Segments Analysis

Global Nerve Repair and Regeneration Market is segmented by Product, Surgery and region. Based on Product, the market is segmented into Biomaterials and Neurostimulation and Neuromodulation Devices. Based on Surgery, the market is segmented into Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and Neurostimulation and Neuromodulation Surgeries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is primarily propelled by the rising incidence of neurological disorders such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and spinal cord injuries. As the global population continues to age and lifestyle factors contribute to an uptick in these conditions, the demand for effective therapies becomes increasingly critical. This surge in the market is particularly evident in developed countries with advanced healthcare systems, where nerve repair treatments are gaining significant traction. Overall, the combination of an aging populace and the prevalence of neurological afflictions is fostering robust growth in this sector.

Restraints in the Global Nerve Repair and Regeneration Market

A major challenge hindering the adoption of advanced nerve repair solutions, like stem cell therapies and regenerative medicine, is their high cost. These innovative treatments often demand substantial financial investments in both technology and research, making them inaccessible to many patients, particularly in low- and middle-income nations. The considerable treatment expenses further limit the feasibility of widespread implementation, posing a significant barrier to market growth, especially in regions facing healthcare budgetary limitations. As a result, the high pricing of these cutting-edge therapies plays a crucial role in restraining the overall expansion of the global nerve repair and regeneration market.

Market Trends of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is witnessing a significant shift towards less invasive techniques, driven by the demand for shorter recovery times, reduced pain, and lower complication rates. The adoption of advanced technologies such as laparoscopic surgery, endoscopy, and robot-assisted procedures is becoming increasingly prevalent in the treatment of nerve injuries. This trend not only enhances patient outcomes but also streamlines clinical workflows, favorably expanding market potential. As healthcare providers and patients alike prioritize minimally invasive options, the market is poised for growth, reflecting an evolving therapeutic landscape in nerve regeneration and repair.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Macroeconomic Indicators
• Top Investment Analysis

Global Nerve Repair and Regeneration Market by Product Type

• Market Overview
• Neurostimulation and Neuromodulation Devices
• Biomaterials

Global Nerve Repair and Regeneration Market by Application

• Market Overview
• Peripheral Nerve Injury
• Epilepsy
• Parkinson's Disease
• Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2024

Key Company Profiles

• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AxoGen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Matrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synovis Micro Companies Alliance, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StimGuard LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexeon MedSystems Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Checkpoint Surgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments